RESÚMENES FEBRERO 2006

.

Psychotic Disorders & Antipsychotics

(Haga un click en la información del journal para acceder al resúmen)

 

Psychosis among "healthy" siblings of schizophrenia patients
Ritva Arajarvi, Jonna Ukkola, Jari Haukka, Jaana Suvisaari, Jukka Hintikka, Timo Partonen and Jouko Lonnqvist
BMC Psychiatry 2006, 6:6; 31 January 2006

 

Region specific distribution of levomepromazine in the human brain

J. Kornhuber, H. Weigmann, J. Röhrich, J. Wiltfang, S. Bleich, I. Meineke, R. Zöchling, S. Härtter, P. Riederer and C. Hiemke

Journal of Neural Transmission 2006;  Volume 113, Number 3: 387 - 397

 

Schizophrenia, antipsychotics and diabetes: Genetic aspects

F. Bellivier

European Psychiatry. Volume 20, Supplement 4, December 2005, Pages S335-S339

 

Data on diabetes from the French cohort study in schizophrenia

A. Philippe, G. Vaiva and F. Casadebaig

European Psychiatry. Volume 20, Supplement 4, December 2005, Pages S340-S344

 

Schizophrenia and diabetes: Epidemiological data

F. Rouillon and F. Sorbara

European Psychiatry. Volume 20, Supplement 4, December 2005, Pages S345-S348

 

Why Olanzapine Beats Risperidone, Risperidone Beats Quetiapine, and Quetiapine Beats Olanzapine: An Exploratory Analysis of Head-to-Head Comparison Studies of Second-Generation Antipsychotics

Stephan Heres, John Davis, Katja Maino, Elisabeth Jetzinger, Werner Kissling, and Stefan Leucht

Am J Psychiatry 163:185-194, February 2006

 

Neurological soft signs, clinical symptoms and treatment reactivity in patients suffering from first episode schizophrenia

Radovan Prikryl, Eva Ceskova, Tomas Kasparek and Hana Kucerova

Journal of Psychiatric Research. Volume 40, Issue 2, March 2006, Pages 141-146

 

Transcranial magnetic stimulation in the treatment of schizophrenic symptoms: A double blind sham controlled study

G. Saba, C.M. Verdon, K. Kalalou, J.F. Rocamora, G. Dumortier, R. Benadhira, L. Stamatiadis, E. Vicaut, H. Lipski and D. Januel

Journal of Psychiatric Research. Volume 40, Issue 2, March 2006, Pages 147-152

 

Analysis of differential clinical profiles of different antipsychotic molecules in the first psychotic episode: a retrospective study
Spanarello S, Beoni AM, Mina G, Amantini K, Colotto A

Encephale. 2005 Nov-Dec;31(6 Pt 1):692-7

 

Obsessive–compulsive disorder in elderly schizophrenia patients

Michael Poyurovsky, Josef Bergman and Ronit Weizman

Journal of Psychiatric Research. Volume 40, Issue 3, April 2006, Pages 189-191

 

Specific executive dysfunction in patients with first-episode medication-naïve schizophrenia

Raymond C.K. Chan, Eric Y.H. Chen and C.W. Law

Schizophrenia Research. Volume 82, Issue 1, 15 February 2006, Pages 51-64

 

Brain morphology in first-episode schizophrenia: A meta-analysis of quantitative magnetic resonance imaging studies

A. Vita, L. De Peri, C. Silenzi and M. Dieci

Schizophrenia Research. Volume 82, Issue 1, 15 February 2006, Pages 75-88

 

Risperidone in first-episode psychosis: A longitudinal, exploratory voxel-based morphometric study

Ragy R. Girgis, Vaibhav A. Diwadkar, Jeffrey J. Nutche, John A. Sweeney, Matcheri S. Keshavan and Antonio Y. Hardan

Schizophrenia Research. Volume 82, Issue 1, 15 February 2006, Pages 89-94

 

Electronically monitored adherence in outpatients with schizophrenia or schizoaffective disorder: A comparison of first- vs. second-generation antipsychotics

Paul A. Nakonezny and Matthew J. Byerly

Schizophrenia Research. Volume 82, Issue 1, 15 February 2006, Pages 107-114

 

D-Alanine Added to Antipsychotics for the Treatment of Schizophrenia

Guochuan E. Tsai, Pinchen Yang, Yue-Cune Chang and Mian-Yoon Chong

Biological Psychiatry. Volume 59, Issue 3, 1 February 2006, Pages 230-234

 

Effects of antipsychotics on brain structure
Scherk, Harald; Falkai, Peter

Current Opinion in Psychiatry. 19(2):145-150, March 2006

Is the glycine site half saturated or half unsaturated? Effects of glutamatergic drugs in schizophrenia patients
Javitt, Daniel C

Current Opinion in Psychiatry. 19(2):151-157, March 2006

Meta-analysis of drop-out rates in randomised clinical trials, comparing typical and atypical antipsychotics in the treatment of schizophrenia

José Luis R. Martin, Víctor Pérez, Montse Sacristán, Fernando Rodríguez-Artalejo, Cristóbal Martínez and Enric Álvarez

European Psychiatry. Volume 21, Issue 1, January 2006, Pages 11-20

 

A prospective evaluation of adherence to medication in first episode schizophrenia

M. Kamali, B.D. Kelly, M. Clarke, S. Browne, M. Gervin, A. Kinsella, A. Lane, C. Larkin and E. O'Callaghan

European Psychiatry. Volume 21, Issue 1, January 2006, Pages 29-33

 

Randomised clinical trial comparing oral versus depot formulations of zuclopenthixol in patients with schizophrenia and previous violence

C. Arango, I. Bombín, T. González-Salvador, I. García-Cabeza and J. Bobes

European Psychiatry. Volume 21, Issue 1, January 2006, Pages 34-40

 

Antipsychotic type and correlates of antipsychotic treatment discontinuation in the outpatient treatment of schizophrenia

Josep Maria Haro, Diego Novick, Mark Belger, Peter B. Jones and SOHO advisory board

European Psychiatry. Volume 21, Issue 1, January 2006, Pages 41-47

 

Clozapine Alone versus Clozapine and Risperidone with Refractory Schizophrenia

William G. Honer, Allen E. Thornton, Eric Y.H. Chen, Raymond C.K. Chan, Jessica O.Y. Wong, Andrea Bergmann, Peter Falkai, Edith Pomarol-Clotet, Peter J. McKenna, Emmanuel Stip, Richard Williams, G. William MacEwan, Kishor Wasan, Ric Procyshyn, for the Clozapine and Risperidone Enhancement (CARE) Study Group

NEJM 2006 FebVolume 354(5):472-482

 

Neurological Abnormalities in Schizophrenic Twins

Marco M. Picchioni, Timothea Toulopoulou, Sabine Landau, Nadia Davies, Tracy Ribchester and Robin M. Murray

Biological Psychiatry. Volume 59, Issue 4, 15 February 2006, Pages 341-348

 

A randomized double-blind 12-week study of quetiapine, risperidone or fluphenazine on sexual functioning in people with schizophrenia

Deanna L. Kelly and Robert R. Conley

Psychoneuroendocrinology. Volume 31, Issue 3, April 2006, Pages 340-346

 

Reviewing the use of antipsychotic drugs in people with intellectual disability

Giampaolo La Malfa, Stefano Lassi, Marco Bertelli, Alessandro Castellani

Human Psychopharmacology: Clinical and Experimental Volume 21, Issue 2, Pages 73 - 89

 

One year outcome in first episode schizophrenia. Predictors of relapse

A. Üçok, A. Polat, S. Çakır and A. Genç

European Archives of Psychiatry and Clinical Neuroscience 2006;  Volume 256, Number 1: 37 - 43

 

Time to discontinuation of atypical versus typical antipsychotics in the naturalistic treatment of schizophrenia
Haya Ascher-Svanum, Baojin Zhu, Douglas Faries, Ron Landbloom, Marvin Swartz and Jeff Swanson
BMC Psychiatry 2006, 6:8; 21 February 2006

.

Regresar a RESÚMENES FEBRERO 2006